Bridge Medicines

Business Area(s): 


Bridge Medicines is a fully funded, professionally staffed biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. 

New York NY
United States